| Identification | More | [Name]
4-(Bromoacetyl)pyridine hydrobromide | [CAS]
5349-17-7 | [Synonyms]
2-BROMO-1-(4-PYRIDINYL)-1-ETHANONE HYDROBROMIDE
2-BROMO-1-PYRDIN-4-YLETHAN-1-ONE HYDROBROMIDE
4-(2-BROMO-ACETYL)-PYRIDINIUM, BROMIDE
4-(BROMOACETYL)PYRIDINE HYDROBROMIDE
BUTTPARK 37\12-45
2-Bromo-1-pyridin-4-ylethanone hydrobromide
2-Bromo-1-pyrdin-3-ylethan-1-one hydrobromide
2-Bromo-1-(pyridin-4-yl)ethan-1-one hydrobromide
4-( Bromoacetyl)pyridine
ETHANONE,2-BROMO-1-(4-PYRIDINYL)-,HYDROBROMIDE | [EINECS(EC#)]
621-664-3 | [Molecular Formula]
C7H7Br2NO | [MDL Number]
MFCD02681893 | [Molecular Weight]
280.94 | [MOL File]
5349-17-7.mol |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S37/39:Wear suitable gloves and eye/face protection . | [Hazard Note ]
Irritant | [HazardClass ]
8 | [HS Code ]
2933399990 |
| Hazard Information | Back Directory | [Uses]
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole. | [Synthesis]
General procedure for the synthesis of 4-(bromoacetyl)pyridine hydrobromide from 4-acetylpyridine: 558 g of batch master batch was added to a reaction flask, followed by the addition of 42 g of ethyl acetate, and 121.1 g of 4-acetylpyridine was added slowly with stirring, keeping the reaction temperature at 20~30 °C and stirring well. N-bromosuccinimide (NBS) 186.9 g was added in batches, followed by slow warming to 65~75 °C. The progress of the reaction was monitored by thin layer chromatography (TLC) until the feedstock was fully reacted. After completion of the reaction, the reaction mixture was cooled to 0~10°C to allow complete crystallization of the product. The crystals were collected by filtration, washed and pulped with 650 g of deionized water, filtered again, and dried to give 275.6 g of 4-(bromoacetyl)pyridine hydrobromide as a white solid in 98.1% molar yield. | [References]
[1] Patent: WO2005/73225, 2005, A1. Location in patent: Page/Page column 49-50
[2] Patent: CN106632001, 2017, A. Location in patent: Paragraph 0026; 0027; 0028; 0029
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 2, p. 787 - 797
[4] Patent: WO2009/158393, 2009, A1. Location in patent: Page/Page column 51
[5] Patent: US2007/142415, 2007, A1. Location in patent: Page/Page column 17 |
|
|